03/12/2025
🚀 MB PHARMA, together with its sister company FAGOFARMA, is launching a new Deep Tech project – “Development of medicinal products DUOFAG® and TRIOFAG® based on safe and effective bacteriophages.” 🦠
Together, we are bringing phage therapy closer to patients by developing functional prototypes for clinical testing and building two GMP pilot production units, marking an important step toward a new generation of antimicrobial treatments.
This project is co-funded by the European Union through the Operational Programme Technology and Application for Competitiveness (OP TAK) and the Ministry of Industry and Trade of the Czech Republic 🇪🇺🤝🇨🇿